Search

Author/Creator Azuma, Fumihiko

1. P2‐002: Assessment of The Safety, Tolerability, Pharmacokinetics, and Effects on Plasma and Cerebrospinal Fluid AB Peptides of AZD3293, a Novel Bace1 Inhibitor, in Healthy Japanese Adults. (1st July 2016)

Authors:
Yoshihara, Tatsuya; Sakamoto, Kei; Matsuki, Shunji; Matsuguma, Kyoko; Uchida, Naoki; Azuma, Fumihiko; Russell, Muir; Hughes, Glen; Haeberlein, Samantha Budd; Alexander, Robert C.; Kugler, Alan R.
Journal:
Alzheimer's & dementia
Issue:
Volume 12:Supplement 7S(2016)Part 12
Page Start:
P608
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid Aβ Peptides. (15th June 2017)

Authors:
Sakamoto, Kei; Matsuki, Shunji; Matsuguma, Kyoko; Yoshihara, Tatsuya; Uchida, Naoki; Azuma, Fumihiko; Russell, Muir; Hughes, Glen; Haeberlein, Samantha Budd; Alexander, Robert C.; Eketjäll, Susanna; Kugler, Alan R.
Journal:
Journal of clinical pharmacology
Issue:
Volume 57:Number 11(2017)
Page Start:
1460
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗